These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29219946)

  • 1. C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro.
    Fan YJ; Zhou YX; Zhang LR; Lin QF; Gao PZ; Cai F; Zhu LP; Liu B; Xu JH
    Acta Pharmacol Sin; 2018 Apr; 39(4):649-658. PubMed ID: 29219946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells.
    Wu L; Yu J; Chen R; Liu Y; Lou L; Wu Y; Huang L; Fan Y; Gao P; Huang M; Wu Y; Chen Y; Xu J
    Clin Cancer Res; 2015 Feb; 21(4):833-43. PubMed ID: 25501124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway.
    Ju HQ; Wang SX; Xiang YF; Liu Z; Liu JY; Chen ZP; Zeng FL; Xia M; Liu ZH; Xing GW; Wang SY; Wang YF
    Eur J Pharmacol; 2011 Sep; 666(1-3):26-34. PubMed ID: 21620825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
    He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W
    Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
    Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 N- and C-terminal double inhibition synergistically suppresses Bcr-Abl-positive human leukemia cells.
    Chen C; Zhuang Y; Chen X; Chen X; Li D; Fan Y; Xu J; Chen Y; Wu L
    Oncotarget; 2017 Feb; 8(6):10025-10036. PubMed ID: 28036294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C0818, a novel curcumin derivative, induces ROS-dependent cytotoxicity in human hepatocellular carcinoma cells in vitro via disruption of Hsp90 function.
    Abdelmoaty AAA; Zhang P; Lin W; Fan YJ; Ye SN; Xu JH
    Acta Pharmacol Sin; 2022 Feb; 43(2):446-456. PubMed ID: 33824458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
    Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
    Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1.
    Hassanzadeh A; Hosseinzadeh E; Rezapour S; Vahedi G; Haghnavaz N; Marofi F
    Anticancer Agents Med Chem; 2019; 19(12):1523-1534. PubMed ID: 31362681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition.
    Ye M; Huang W; Wu WW; Liu Y; Ye SN; Xu JH
    Oncotarget; 2017 Feb; 8(9):15364-15376. PubMed ID: 28157708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].
    Li BJ; Liu TB; Wang WF; Lin MH; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):1-7. PubMed ID: 26913384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
    Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D
    Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice.
    Jin L; Xiao CL; Lu CH; Xia M; Xing GW; Xiong S; Liu QY; Liu H; Li YC; Ge F; Wang QD; He QY; Wang YF
    FEBS Lett; 2009 Jun; 583(12):1859-66. PubMed ID: 19427857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
    Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy.
    Liu B; Shen Y; Huang H; Croce KD; Wu M; Fan Y; Liu Y; Xu J; Yao G
    Cell Commun Signal; 2020 Sep; 18(1):159. PubMed ID: 32993709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo.
    Wang W; Liu Y; Zhao Z; Xie C; Xu Y; Hu Y; Quan H; Lou L
    Cancer Sci; 2016 Jun; 107(6):782-90. PubMed ID: 27002306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.
    Wu LX; Xu JH; Huang XW; Zhang KZ; Wen CX; Chen YZ
    Acta Pharmacol Sin; 2006 Jun; 27(6):694-9. PubMed ID: 16723087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
    Wong SM; Liu FH; Lee YL; Huang HM
    PLoS One; 2016; 11(1):e0148093. PubMed ID: 26815740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.